B-cell targeted therapies show durable immune responses in pemphigus vulgaris and myasthenia gravis
New data shows how B-cell therapies treat autoimmune diseases
This systematic review of 24 clinical trials involving more than 3,500 participants evaluates B-cell targeted therapies for various autoimmu…
New research highlights how targeting specific immune cells can provide lasting relief for several different autoimmune conditions.
Dupilumab as an off-label adjunctive approach facilitates corticosteroid minimization in severe pemphigus vulgaris
New approach helps manage severe skin disease with fewer steroids
This case report describes the use of dupilumab as an off-label adjunctive corticosteroid-minimizing approach for a patient with severe muco…
A new way to treat a severe blistering skin disease may help patients who cannot safely take high doses of steroids.